Australia markets closed

Medpace Holdings, Inc. (MEDP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
386.34+0.64 (+0.17%)
At close: 04:00PM EDT
386.34 0.00 (0.00%)
After hours: 05:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.99B
Enterprise value 11.72B
Trailing P/E 39.45
Forward P/E 35.97
PEG ratio (5-yr expected) 2.13
Price/sales (ttm)6.27
Price/book (mrq)17.85
Enterprise value/revenue 5.97
Enterprise value/EBITDA 30.67

Trading information

Stock price history

Beta (5Y monthly) 1.40
52-week change 378.42%
S&P500 52-week change 323.49%
52-week high 3421.00
52-week low 3207.47
50-day moving average 3394.66
200-day moving average 3320.38

Share statistics

Avg vol (3-month) 3225.59k
Avg vol (10-day) 3159.41k
Shares outstanding 530.98M
Implied shares outstanding 631.13M
Float 825.42M
% held by insiders 117.70%
% held by institutions 185.43%
Shares short (15 May 2024) 4902.47k
Short ratio (15 May 2024) 43.44
Short % of float (15 May 2024) 44.38%
Short % of shares outstanding (15 May 2024) 42.91%
Shares short (prior month 15 Apr 2024) 4984.45k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 15.92%
Operating margin (ttm)20.36%

Management effectiveness

Return on assets (ttm)13.89%
Return on equity (ttm)61.35%

Income statement

Revenue (ttm)1.96B
Revenue per share (ttm)63.97
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)N/A
EBITDA 382.05M
Net income avi to common (ttm)312.32M
Diluted EPS (ttm)9.83
Quarterly earnings growth (yoy)40.70%

Balance sheet

Total cash (mrq)407.01M
Total cash per share (mrq)13.17
Total debt (mrq)158.13M
Total debt/equity (mrq)23.55%
Current ratio (mrq)0.78
Book value per share (mrq)21.72

Cash flow statement

Operating cash flow (ttm)505.98M
Levered free cash flow (ttm)405.63M